Koninklijke Philips Retained Earnings (Accumulated Deficit) 2010-2025 | PHG

Koninklijke Philips retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Koninklijke Philips retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $3.927B, a 54.15% decline year-over-year.
  • Koninklijke Philips retained earnings (accumulated deficit) for 2024 were $3.95B, a 32.44% decline from 2023.
  • Koninklijke Philips retained earnings (accumulated deficit) for 2023 were $5.847B, a 18.78% decline from 2022.
  • Koninklijke Philips retained earnings (accumulated deficit) for 2022 were $7.198B, a 34.89% decline from 2021.
Koninklijke Philips Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $3,950
2023 $5,847
2022 $7,198
2021 $11,055
2020 $8,942
2019 $9,292
2018 $9,762
2017 $9,716
2016 $9,111
2015 $8,928
2014 $11,685
2013 $13,834
2012 $13,778
2011 $17,991
2010 $20,587
2009 $22,240
Koninklijke Philips Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2025-03-31 $3,927
2024-06-30 $4,019
2023-06-30 $5,831
2023-03-31
2022-06-30 $8,566
2021-06-30 $8,764
2020-06-30 $7,392
2019-06-30
2018-06-30 $9,535
2017-06-30 $9,153
2016-12-31 $9,111
2016-09-30 $9,058
2016-06-30 $8,806
2016-03-31 $8,816
2015-12-31 $8,928
2015-09-30 $9,524
2015-06-30 $9,121
2015-03-31 $9,834
2014-12-31 $11,685
2014-09-30 $12,675
2014-06-30 $13,308
2014-03-31 $14,111
2013-12-31 $13,834
2013-09-30 $13,122
2013-06-30 $13,619
2013-03-31 $14,334
2012-12-31 $13,778
2012-09-30 $14,181
2012-06-30 $16,011
2012-03-31 $17,174
2011-12-31 $17,991
2011-09-30 $19,146
2011-06-30 $19,419
2011-03-31 $20,293
2010-12-31 $20,587
2010-09-30 $21,041
2010-06-30 $20,122
2010-03-31 $21,507
2009-12-31 $22,240
2009-09-30 $21,204
2009-06-30 $19,961
2009-03-31 $21,467
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.476B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.206B 27.56
Boston Scientific (BSX) United States $152.664B 38.22
Stryker (SYK) United States $149.191B 31.19
EssilorLuxottica (ESLOY) France $131.913B 0.00
Medtronic (MDT) Ireland $115.147B 16.32
Lonza Group Ag (LZAGY) Switzerland $50.094B 0.00
Haleon (HLN) United Kingdom $43.531B 24.85
ResMed (RMD) United States $37.280B 28.00
GE HealthCare Technologies (GEHC) United States $34.547B 16.40
Agilent Technologies (A) United States $32.221B 21.01
Terumo (TRUMY) Japan $24.355B 31.64
Insulet (PODD) United States $20.287B 79.63
Zimmer Biomet Holdings (ZBH) United States $18.641B 11.97
Baxter (BAX) United States $14.559B 10.87
Smith & Nephew SNATS (SNN) United Kingdom $12.951B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.729B 23.42
Lantheus Holdings (LNTH) United States $5.148B 12.99
Perrigo (PRGO) Ireland $3.724B 9.44
Prestige Consumer Healthcare (PBH) United States $3.715B 16.59
Haemonetics (HAE) United States $3.575B 16.28
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.342B 27.77
ICU Medical (ICUI) United States $3.072B 22.66
LeMaitre Vascular (LMAT) United States $1.867B 41.72
QuidelOrtho (QDEL) United States $1.864B 12.82
AtriCure (ATRC) United States $1.504B 0.00
Acuren (TIC) United States $1.431B 0.00
Phibro Animal Health (PAHC) United States $1.238B 15.82
AdaptHealth (AHCO) United States $1.232B 12.51
Green Thumb Industries (GTBIF) United States $1.212B 27.26
Neogen (NEOG) United States $1.068B 13.67
BioLife Solutions (BLFS) United States $1.006B 0.00
InMode (INMD) Israel $0.901B 9.08
Kestra Medical Technologies (KMTS) United States $0.788B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.642B 0.00
Owens & Minor (OMI) United States $0.613B 5.08
Tilray Brands (TLRY) Canada $0.607B 0.00
Evolus (EOLS) United States $0.593B 0.00
CeriBell (CBLL) United States $0.571B 0.00
Valneva SE (VALN) France $0.552B 0.00
Surmodics (SRDX) United States $0.446B 0.00
SNDL (SNDL) Canada $0.392B 0.00
Capricor Therapeutics (CAPR) United States $0.331B 0.00
VAREX IMAGING (VREX) United States $0.321B 11.82
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.300B 0.00
Quanterix (QTRX) United States $0.283B 0.00
Cerus (CERS) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.30
Cresco Labs (CRLBF) United States $0.260B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.67
Sanara MedTech (SMTI) United States $0.248B 0.00
ZimVie (ZIMV) United States $0.243B 11.04
OraSure Technologies (OSUR) United States $0.239B 0.00
Brainsway (BWAY) Israel $0.230B 60.75
Biote (BTMD) United States $0.224B 6.31
Omeros (OMER) United States $0.206B 0.00
Canopy Growth (CGC) Canada $0.202B 0.00
Verano Holdings (VRNOF) United States $0.200B 0.00
High Tide (HITI) Canada $0.197B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.87
TriSalus Life Sciences (TLSI) United States $0.178B 0.00
Vireo Growth (VREOF) United States $0.152B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.123B 15.16
TerrAscend (TSNDF) Canada $0.101B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.100B 12.87
MacroGenics (MGNX) United States $0.096B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Jushi Holdings (JUSHF) United States $0.075B 0.00
Zynex (ZYXI) United States $0.069B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.068B 0.00
Cytosorbents (CTSO) United States $0.065B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
United-Guardian (UG) United States $0.043B 14.76
Modular Medical (MODD) United States $0.038B 0.00
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.037B 49.29
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00